Latest News

Timely, factual reporting across artificial intelligence, cybersecurity, companies and markets, EU AI regulation, health and biotech, and climate and energy.

  1. The global Phase III trial enrolled 594 patients with previously treated, CLDN18.2-positive gastric or related cancers.

  2. The proposed Kimberley campus would use a private microgrid, with up to 5,200MW of solar and 1,500MW of wind capacity.

  3. Genmab will conduct the proposed trial, and Incyte plans to share its funding and provide INCB161734.

  4. The phase 2a study enrolled 31 patients who could not receive or declined cisplatin-based chemotherapy.

  5. Singapore’s Energy Market Authority said the reduction is less than 2% of the city-state’s daily gas demand.

  6. Brent’s 3.14% daily gain put the benchmark at $116.72 per barrel at Friday’s settlement, Reuters reported.

  7. Block said the research preview requires a MacBook Pro with an M4 Max chip or better for local use.

  8. First Hawaiian reported $14.5 billion in gross loans and leases at September 30, down $115.1 million from the prior quarter.

  9. The phase 2 study enrolled 144 patients with resected pancreatic cancer and compared camupepimut with observation.

  10. OpenAI said its red-team tests used hundreds of billions of tokens in isolated replicas of research infrastructure.